Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Condition: Hepatitis CInterventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin; Drug: telaprevirSponsor: University of ChicagoTerminated - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2012 Category: Research Source Type: clinical trials
Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis CInterventions: Drug: Telaprevir + peginterferon alfa + ribavirin; Drug: peginterferon alfa + ribavirin; Drug: peginterferon alfa + ribavirinSponsor: Janssen-Cilag International NVAvailable - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2012 Category: Research Source Type: clinical trials
Telaprevir Open-Label Study in Co-Infected Patients
Condition: Hepatitis C, ChronicInterventions: Drug: Telaprevir; Drug: TelaprevirSponsor: Janssen-Cilag International NVCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: mericitabine; Drug: mericitabine; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: mericitabine; Drug: mericitabine; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: mericitabine; Drug: mericitabine; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: mericitabine; Drug: mericitabine; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: mericitabine; Drug: mericitabine; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: mericitabine; Drug: mericitabine; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
